During the past decade, Irkutsk Regional Consulting and Diagnostic Clinical Center; Regional Center of Reumatolodic Deasise conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Irkutsk Regional Consulting and Diagnostic Clinical Center; Regional Center of Reumatolodic Deasise" are "Hepatitis C, Chronic" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Irkutsk Regional Consulting and Diagnostic Clinical Center; Regional Center of Reumatolodic Deasise" in a lesser frequency.

Most popular intervention types in "Irkutsk Regional Consulting and Diagnostic Clinical Center; Regional Center of Reumatolodic Deasise" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DMARDs (disease-modifying antirheumatic drugs)" (1 trials), "Peginterferon alfa-2a" (1 trials), "Ribavirin" (1 trials) and "tocilizumab [RoActemra/Actemra]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Irkutsk Regional Consulting and Diagnostic Clinical Center; Regional Center of Reumatolodic Deasise" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Irkutsk Regional Consulting and Diagnostic Clinical Center; Regional Center of Reumatolodic Deasise". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Irkutsk Regional Consulting and Diagnostic Clinical Center; Regional Center of Reumatolodic Deasise, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Irkutsk Regional Consulting and Diagnostic Clinical Center; Regional Center of Reumatolodic Deasise, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".